A detailed history of Tower Research Capital LLC (Trc) transactions in Olink Holding Ab (Publ) stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,737 shares of OLK stock, worth $71,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,737
Previous 3,736 26.74%
Holding current value
$71,162
Previous $93,000 31.18%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$21.81 - $25.14 $21,788 - $25,114
-999 Reduced 26.74%
2,737 $64,000
Q4 2023

Feb 13, 2024

SELL
$14.29 - $25.95 $20,491 - $37,212
-1,434 Reduced 27.74%
3,736 $93,000
Q3 2023

Nov 14, 2023

BUY
$14.45 - $20.34 $74,706 - $105,157
5,170 New
5,170 $76,000
Q1 2023

May 09, 2023

BUY
$19.34 - $24.11 $104,919 - $130,796
5,425 Added 262.58%
7,491 $169,000
Q4 2022

Feb 10, 2023

SELL
$12.64 - $25.52 $119,637 - $241,546
-9,465 Reduced 82.08%
2,066 $52,000
Q3 2022

Nov 10, 2022

BUY
$12.14 - $18.42 $139,986 - $212,401
11,531 New
11,531 $140,000
Q2 2022

Aug 15, 2022

SELL
$8.95 - $19.24 $31,324 - $67,340
-3,500 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$11.33 - $19.3 $31,825 - $54,213
-2,809 Reduced 44.52%
3,500 $62,000
Q4 2021

Feb 14, 2022

BUY
$18.0 - $34.82 $113,562 - $219,679
6,309 New
6,309 $115,000
Q3 2021

Nov 15, 2021

SELL
$23.42 - $37.93 $2,342 - $3,793
-100 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$26.65 - $39.47 $239 - $355
-9 Reduced 8.26%
100 $3,000
Q1 2021

May 17, 2021

BUY
$31.9 - $36.0 $3,477 - $3,924
109 New
109 $4,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Market Cap $3.1B
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.